Ensemble Discovery, Roche Collaborate on EGFR Assays for Cancer Drug Response | GenomeWeb
NEW YORK (GenomeWeb news) – Ensemble Discovery said today that it has extended an existing collaboration with Roche that is using Ensemble’s diagnostic assays to analyze proteins in cancer tissues in an effort to develop new treatment tools.
Under the extended agreement, the companies aim to develop product prototypes that detect EGFR receptor dimers in cancer samples. Ensemble said that it will develop a test that will correlate particular EGFR family dimer patterns with the efficacy of certain anti-cancer drugs.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.